DaVita Inc. has announced the appointment of Dennis Pullin to its Board of Directors, effective April 10, 2024.
“Pleased to welcome Dennis to DaVita’s board,” said Pamela Arway, independent chair of the DaVita Inc. Board of Directors. “Excited about the perspective Dennis will bring to the Board and look forward to his positive impact on our future growth and performance.”
Dennis Pullin brings over 30 years of healthcare leadership experience, serving in executive roles in hospitals, academic medical centers, physician group practices, and private industry. He currently serves as president and CEO of Virtua Health, a $2 billion non-profit academic health system in New Jersey.
“Dennis’ healthcare background complements the skills of the overall Board,” said Javier Rodriguez, CEO of DaVita Inc. “Excited about the perspectives he will bring as we continue to live our vision of an unwavering pursuit of a healthier tomorrow.”
“It’s an honor to join the Board,” said Mr. Pullin. “I look forward to playing a role in the continued transformation of kidney care delivery.”
With Mr. Pullin’s addition, the DaVita Board now comprises 11 highly qualified directors, with over 50 percent board diversity. Mr. Pullin will serve on the Compliance and Quality Committee.
For more information about DaVita and its Board of Directors, visit DaVita.com/About.
About DaVita Inc.
DaVita (NYSE: DVA) is a healthcare provider focused on transforming care delivery to improve quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. DaVita serves patients at every stage and setting along their kidney health journey, from slowing the progression of kidney disease to supporting transplantation and providing acute hospital care to dialysis at home. As of December 31, 2023, DaVita served approximately 250,200 patients at 3,042 outpatient dialysis centers worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to advance equitable and high-quality standards of care for all patients.
